Where can zolbetuximab be purchased easily?

Zolbetuximab (zolbetuximab)-Vyloy is a monoclonal antibody targeting CLDN18.2-positive tumors. Its main indications are advanced or metastatic gastric cancer and gastroesophageal junction cancer. CLDN18.2 is highly expressed in most patients with advanced gastric cancer. Zotuximab can enhance the immune system's ability to attack cancer cells by targeting this molecule, thereby inhibiting tumor growth. Clinically, zotuximab is often used in combination with chemotherapy regimens to improve efficacy, delay disease progression, and improve patients' quality of life.

In China, the originator drug of zotuximab has been officially launched, but it has not yet been included in the medical insurance catalog. Therefore, you need to consult the local hospital pharmacy or drug supplier for the price. Before purchasing drugs, doctors usually recommend that patients undergo molecular testing to confirm CLDN18.2 expression to ensure the effectiveness of targeted therapy. Internationally, zotuximab is available in European and Japanese versions, providing protection for patients in different regions. Since biologics have strict storage and transportation requirements, patients should obtain drugs through regular hospital pharmacies or designated channels to ensure quality and efficacy.

Patients taking zotuximab also need to pay attention to monitoring during treatment, including hematology, imaging and infusion reaction assessment. Doctors will develop an individualized plan based on the condition, previous treatment history and tolerance, and closely observe immune-related side effects, such as rash, fatigue and gastrointestinal discomfort during medication. Scientific management and standardized medication can reduce risks while ensuring efficacy, and provide accurate and safe treatment options for patients with CLDN18.2-positive advanced gastric cancer.

In summary, zotuximab has clear indications, precise targeting, formal purchase channels, and requires combination of molecular testing and professional management, providing an important treatment option for patients with advanced gastric cancer. Through rational use and monitoring, patients can maximize drug efficacy while safely enjoying the advantages of precision immunotherapy.

Reference materials:https://www.astellas.com/en/news/29401